je.st
news
Home
› Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse
Sosei Subsidiary Heptares Awarded $5.5M Research & Development Grant From The US National Institute On Drug Abuse
2015-09-30 08:19:49| drugdiscoveryonline News Articles
Sosei Group Corporation is pleased to announce that its wholly-owned subsidiary Heptares Therapeutics (“Heptares”) has been awarded a grant from the National Institute on Drug Abuse (NIDA), one of the US National Institutes of Health
Tags: research
development
national
abuse
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||